R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Market Access Pharmacogenomics and IVDR: Overcoming transition challenges In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
